0001562180-17-000880.txt : 20170223
0001562180-17-000880.hdr.sgml : 20170223
20170223160216
ACCESSION NUMBER: 0001562180-17-000880
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170221
FILED AS OF DATE: 20170223
DATE AS OF CHANGE: 20170223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hadas Nicole R.
CENTRAL INDEX KEY: 0001602396
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 17632407
MAIL ADDRESS:
STREET 1: 20 PILGRAM DRIVE
CITY: WINCHESTER
STATE: MA
ZIP: 01890
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-02-21
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001602396
Hadas Nicole R.
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
SVP, General Counsel, Sec.
Common Stock
2017-02-21
4
A
false
28500.00
0.00
A
111412.00
D
Stock Option (Right to buy)
0.00
2017-02-21
4
A
false
45000.00
10.14
A
2027-02-21
Common Stock
45000.00
45000.00
D
The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date.
25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.
John P. Butler, Attorney-in-Fact for Nicole R. Hadas
2017-02-23